Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07314333) titled 'A Trial to Assess How Centanafadine Interacts With Stimulants in the Body' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition:
ADHD
Intervention:
Drug: Centanafadine
Drug: Methylphenidate
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: February 3, 2026
Target Sample Size: 42
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.go...